SRC and melanoma: TNS3, identified in 2004 [26], has been reported to serve as an oncogene, which is based on Src family kinases (mainly Src) mediated tyrosine phosphorylation of its SH2 domain in several advanced cancers, such as non-small cell lung cancer, breast cancer, and melanoma [21, 27].